Drug intelligence / Profile preview

GelStat Sinus

Development stage: Unknown
Lead developer: GelStat
Modality: Small Molecules
Administration: Sublingual

Overview

GelStat Sinus is an over-the-counter (OTC) healthcare product developed by GelStat Corporation specifically for the treatment of sinus conditions, including sinusitis and allergies. The product is part of the GelStat line of sublingual therapies, which are designed for rapid absorption and ease of administration. It targets a significant market of individuals affected by chronic sinus inflammation and allergy-related symptoms. While the specific active ingredients and biological targets are not detailed in available literature, the product utilizes GelStat's proprietary formulation technology intended to provide effective relief for sinus-related symptoms through a sublingual delivery system.

Brand names: GelStat Sinus

Beyond the preview

Go deeper on GelStat Sinus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GelStat Sinus.

Explore the full profile